Yesterday, 21:10

Magstim Granted EU MDR Certification

Notified -
Globe NewswireYesterday, 21:10
3-04-2025, 18:16

Minovia Therapeutics Announces FDA Clearance of Second IND Application, for a Phase II Clinical Trial of Lead Product MNV-201 in Pearson Syndrome

Notified -
Globe Newswire3-04-2025, 18:16
19-02-2025, 19:05

Boehringer’s zongertinib receives Priority Review from U.S. FDA for the treatment of HER2 (ERBB2)-mutant advanced non-small cell lung cancer

Notified -
Globe Newswire19-02-2025, 19:05
8-10-2024, 18:00

Teva Prolia® (Denosumab) Biosimilar Candidate is Accepted for Review by U.S. FDA and EU EMA
Globe Newswire8-10-2024, 18:00
26-09-2024, 23:34

Minovia Therapeutics Announces FDA Clearance of IND Application for a Phase Ib Clinical Trial of MNV-201 in Low Risk Myelodysplastic Syndrome
Globe Newswire26-09-2024, 23:34
13-03-2023, 22:36

KronosMD Inc CEO to attend the Annual Roth Investor

CEO Dr. Greg Rubin to meet with institutional investors...
Globe Newswire13-03-2023, 22:36
9-03-2023, 22:25

2023 SXSW Conference Hosts Psychedelic Healthcare VC Fund

CHICAGO and NEW YORK, March 09, 2023 (GLOBE NEWSWIRE) -- As therapeutic applications of psychedelics gain more
Globe Newswire9-03-2023, 22:25
3-03-2023, 12:33

Experts Share Insights on Evolving Global Vaccine Landscape

SINGAPORE, March 03, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO with extensive
Globe Newswire3-03-2023, 12:33